Reuters logo
15 天前
BRIEF-Kite Pharma reports Q2 loss of $1.94 per share
2017年8月8日 / 中午12点17分 / 15 天前

BRIEF-Kite Pharma reports Q2 loss of $1.94 per share

Aug 8 (Reuters) - Kite Pharma Inc

* Kite reports second quarter 2017 financial results

* Q2 non-GAAP loss per share $1.50 excluding items

* Q2 loss per share $1.94

* Q2 revenue $10.1 million versus I/B/E/S view $9.6 million

* Q2 earnings per share view $-1.98 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below